The PM Society announces Sumira Riaz as Patient Engagement Interest Group co-chair dlvr.it/T6zNnY #Blogs #Digitalintelligence

New from PMHub - Enhancing Virtual Training: Role-Playing in Meetings – Impetus InSite Tips #7 dlvr.it/T6ytVw #Advisoryboard #DOL #DOL engagement

Bristol Myers Squibb’s Breyanzi granted FDA accelerated approval for follicular lymphoma dlvr.it/T6yfFy #News #Regulatory #Breyanzi

Takeda’s Qdenga becomes second dengue vaccine to receive WHO prequalification dlvr.it/T6yfFc #News #Regulatory #dengue

AstraZeneca’s sipavibart shown to prevent COVID-19 in immunocompromised patients dlvr.it/T6yfFP #News #Research #AstraZeneca

UCB shares positive phase 3 results for Zilbrysq in generalised myasthenia gravis dlvr.it/T6yfD2 #News #Research #generalisedmyastheniagravis

New from PMHub - Exploring medical education and why it relies on real-world research dlvr.it/T6yW9r #HCPengagement #healthcarecommunications #MedEd

Click on the link below to check out Rosamund Round’s article on why understanding all aspects of the patient journey is imperative to successful clinical research: pmlive.com/intelligence/a… #pharma #health #PME

Sanofi gains rights to Fulcrum’s muscular dystrophy treatment in deal worth more than $1bn dlvr.it/T6vyrz #News #Sales #facioscapulohumeralmusculardystrophy

Biogen and Eisai announce rolling FDA submission for injectable version of Alzheimer’s drug dlvr.it/T6vx00 #News #Regulatory #Alzheimersdisease

Roche’s self-collection solution for HPV screening granted FDA approval dlvr.it/T6vwyX #News #Regulatory #cervicalcancer

Trial reveals promising results for radiotherapy/hormone therapy combination in prostate cancer dlvr.it/T6vwxK #News #Research #InstituteofCancerResearch

New from PMHub - Pioneering Paths: Women Leadership in Rare Disease dlvr.it/T6vgf3 #daretothinkrare #raredisease #Womeninhealthcare

In Uptake’s latest column, Cathy Nolan discusses the importance of pharma making bold strategic choices: pmlive.com/blogs/supercha… #pharma #health #PME

Takeda gains exclusive option for AC Immune’s Alzheimer’s drug candidate in deal worth over $2.1bn dlvr.it/T6sFnf #News #Sales #ACImmune

Sanofi, Pfizer and AstraZeneca commit €2.5bn investment to biomanufacturing projects in France dlvr.it/T6sFmg #News #Research #AstraZeneca

Novo Nordisk’s haemophilia A therapy Mim8 shows promise in late-stage study dlvr.it/T6sD83 #News #Research #FRONTIER2

WHO opens application period for 2025 Model Lists of Essential Medicines dlvr.it/T6sD6w #News #Regulatory #EssentialMedicinesforChildren

Click on the link below to check out Thomas Colomer and Chris Eastham’s article on the chief opportunities and challenges for digital health providers in implementing and scaling technological solutions in the UK: pmlive.com/intelligence/d…  #pharma #health #PME

In his latest column, Mike Dixon explores the benefits of welcoming neurodiversity across the healthcare communications industry: pmlive.com/blogs/thinking… #pharma #health #PME